SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " loss " 3,600 found 🔀 AI-powered Shuffle
Kerry loss 'will take a while to get over'
Tyrone midfielder Conn Kilpatrick says the 2-25 to 0-27 All-Ireland SFC quarter-final defeat by Kerry will "take a while to get over".
Carman: Tuesday’s election is more than just a primary. It’s a colossal opportunity to change history.
The template for tyrants goes back at least to Ancient Rome and, as Nero discovered, generally ends badly.
Israeli politicians lash out after Netanyahu announces intention of 'broad national government'
During the press conference, Netanyahu condemned unnamed forces which "want to cause a rift in the people, want to aggravate and deepen the misunderstandings and disagreements and rifts within us."
ABC7 reporter goes viral after declaring she doesn’t want to know anything about Bosnia
An ABC7 Los Angeles reporter has gone viral ahead of the United States’ World Cup round of 32 matchup with Bosnia and Herzegovina next Wednesday in Santa Clara, and not for the right reasons Reporter Abigail Velez, wrapping a live shot from Long Beach following the UMSNT’s group-stage loss to Türkiye, announced proudly that she…
Mets Make Roster Decision After 7th Straight Loss
The New York Mets have made roster decisions before game two against the Phillies.
'Super puffy': Scientists ponder extreme low density of two planets
International researchers are engaged in a complex study of two planets in deep space that appear to have an average density lower than that of candy floss. The planets orbiting star TOI-791, located ...
Leaders of effort to preserve Temporary Protected Status react to Supreme Court loss
Germany news: Heat soars as political reforms split opinion
As Europe's heatwave rages, Germany continues to swelter with new records expected Saturday. Elsewhere, politicians bicker over reforms and industry blames train operator DB for billions in losses. DW has the latest.
Fallout from USMNT loss to Turkey and previewing the Mbappe-Haaland clash
On today’s show, we look back at the United States’ final group stage match against Turkey and evaluate their readiness for the Round of 32. Manchester City insider Sam Lee joins us to preview the tournament’s first true superstar heavyweight clash as Kylian Mbappe and France square off against Erling Haaland and Norway in a battle for Group I supremacy. Plus, The Athletic’s Jay Harris is back in the studio to break down the latest bracketology, advancement percentages, and qualification permutations for Groups G, H, and I using The Athletic’s World Cup Tracker.
No debut, but loud cheers: Belfast crowd shows love for Vaibhav Sooryavanshi
Teenage sensation Vaibhav Sooryavanshi's India debut is still pending, but the focus shifted to Ireland's historic 34-run victory in the first T20I. Despite the loss, Shreyas Iyer vowed a strong comeback. Ireland's debutants impressed, with Jai Moondra and Matt Hollard making immediate impacts, while Abhishek Sharma's quickfire fifty wasn't enough for India.
Walbert Ureña implodes as Angels drop series opener against Athletics
On a night that started with an abrupt front office decision, Los Angeles Angels’ starter Walbert Ureña saw an abrupt end to an outing after a disastrous fifth inning led to a 9-3 loss against the Athletics on Friday.
Caitlin Clark Fans Staging Boycott For Saturday's Fever Game
This Saturday's showdown between the Indiana Fever and Los Angeles Sparks has unfortunately lost some of its appeal due to Caitlin Clark's latest injury. Clark suffered a back injury during Wednesday's loss to the Phoenix Mercury. To make matters worse, she was on the receiving end of a cheap shot ...
House Republican reacts to changing politics under Trump
Republican Rep. Dusty Johnson spoke to NBC News' Garrett Haake about his recent loss in the primary to become the governor of South Dakota, and how he feels about the current political environment under President Trump.
Americans keep poisoning themselves with semaglutide, other weight loss drugs
These incidents became much more common after the FDA started approving GLP-1 drugs for chronic weight management in 2021.
Kylie Jenner's former chef alleges 'intense' workload led to miscarriage
Kylie Jenner has been hit with a third workplace lawsuit as her former chef claims the job's "intense" demands led to a pregnancy loss.
An Incomplete History of Seattle Sports
Sonics, Seahawks, Sounders, Storm, Steelheads, Mariners, Kraken, and more.
Medicare will soon offer some older Oregonians weight loss drugs for $50 a month. Here’s how it works.
Medicare has long excluded coverage of GLP-1s prescribed solely for weight loss.
Is AMC Entertainment Holdings (AMC) Undervalued Or Is Its Recent Rally Already Priced In?
AMC Entertainment Holdings (AMC) is under renewed scrutiny as investors weigh its recent share price swings and ongoing losses against reported revenue of $5,031.8 million and a market value of about $1.5 billion. See our latest analysis for AMC Entertainment Holdings. At a share price of $1.89, AMC Entertainment Holdings has seen sharp swings, with a 7 day share price return down 33.22% but a 90 day share price return up 99.33%. The 1 year total shareholder return is down 37.42%, indicating...
2026 SEC football predictions: Game-by-game picks, projecting every team's final win-loss record
Continuing our early-summer projection series for all 16 teams in the SEC and where they'll end up in the postseason
Corus Entertainment reports $36.5M Q3 loss, revenue down 26 per cent from year ago
TORONTO — Corus Entertainment Inc. reported a net loss attributable to shareholders of $36.5 million in its latest quarter as the company behind Global Television saw its revenue fall 16 per cent compared with a year ago.
'A heavy impact:' Schwebel's closure leaves a sense of community loss
It’s the small things that residents across the region will remember when Schwebel’s closes its doors at summer’s end. Everything from...
Mark Cuban urged AI firms to spend billions on cities hit by job losses
He said this is the "cost of doing business" for the companies that are losing a PR battle with the masses.
4 Takeaways From USA's Last-Second World Cup Loss To Türkiye
So much for a perfect group stage. But the USA can now turn its attention toward the knockout stages.
Troy Melton magnificent but Tigers’ offence falters in loss
Troy Melton had a perfect game into the sixth. Unfortunately, baseball games are nine innings and runs are required.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Mets commit six infield errors in embarrassing loss to Cubs: 'This team is in the depths of despair'
Hims' obesity drug business may get boost as employers drop coverage
Telehealth provider Hims and Hers Health may get a boost next year from employers dropping coverage of weight-loss drugs like Novo Nordisk's Wegovy and Eli Lilly's Zepbound and Foundayo to rein in costs, investors and analysts say.
Washington Nationals vs Philadelphia Phillies Game Thread
Follow along as the Nats look to bounce back from yet another heartbreaking loss where the bullpen imploded
Kennedy scion Jack Schlossberg loses crowded New York City congressional primary
Kennedy family scion and political novice Jack Schlossberg lost Tuesday to New York state Assembly Member Micah Lasher, in a closely watched and crowded Democratic primary for an open congressional seat in the heart of Manhattan.
Political earthquake strikes House Democrats and Hispanic caucus with Espaillat's loss
4 Takeaways From Canada's Group-Stage Finale Loss To Switzerland
Both teams advance to the World Cup knockout round, but one clearly looks better than the other.
Even in Defeat, a Democrat Showed the Upside of Angering the A.I. Industry
Alex Bores’s close loss in New York could pave the way for other Democrats to take political advantage of being attacked by the increasingly unpopular A.I. industry.
Braves blow another one in 7-6 loss to Padres
A wild night at Petco Park was capped off by a walk-off single by way of Manny Machado as the Braves fell to the Padres, 7-6, in 10 innings. This is a bad baseball team at the moment. The second inning was a doozy for both sides. The Braves loaded the bases and cashed in […]
Dartmouth Health reports $63.5 million loss at end of quarter
According to a recent filing, Dartmouth Health lost millions of dollars due to severe winter weather, inflation, and other challenges.
US: Google's YouTube settles teen mental health lawsuit
A Florida teenager said YouTube's addictive design contributed to depression, anxiety and sleep loss. Instagram, Snapchat and TikTok are also facing similar allegations about their impact on young users.
Angels Haunted by Trades in Loss to Orioles
Two past trade deals came back to haunt the Los Angeles Angels during the series opener against the Baltimore Orioles on Monday. The Angels lost 6-1 to the Orioles, with two of the Halos’ former players shining during the game. In the first inning, former Angels outfielder Taylor Ward hit a leadoff home run to […] The post Angels Haunted by Trades in Loss to Orioles appeared first on LA Sports Report.
People on GLP-1 medications are exercising less
A new study found that people using weight-loss drugs are doing less exercise, despite feeling healthier. Here's how muscle mass and bone density are affected.
Taking Wing: Jake Bloss
Today’s subject is in kind of an unusual spot as regards his prospect status. Bloss actually debuted two years ago, and as he turns 25 today (Happy Birthday, Jake) he’s on the fringes of what’s typically considered prospect eligibility. He’s also coming back from Tommy John surgery, which has eaten up the last 14 months […]
Trouble getting weight loss drugs covered by insurance? Here's what to know
If your doctor prescribes a GLP-1 medication for weight loss but your insurance won't cover it, you have options.
Braves offense lifeless again in loss to Padres
The Braves offense was lifeless against Michael King and the San Diego bullpen on Monday night, losing 1-0 to drop their second game in a row. It was more of the same for Grant Holmes, who labored through 4 2/3 innings. He hung a slider to struggling Manny Machado in the fourth inning that was […]
What’s at Stake on a Blockbuster NYC Election Day
Tuesday is make or break for everyone from Jack Schlossberg to Brad Lander and will serve as a major test of Zohran Mamdani’s clout.
Dodgers Claim Narrow Win, 2 Players Exit Game With Injury
The Los Angeles Dodgers took a 2-1 win over the Minnesota Twins on Monday, but suffered two heavy losses in the game.
Reflection deal suggests SpaceX's Colossus could become its own business line
CNBC's Deirdre Bosa reports on news regarding SpaceX.
New Orleans Summer Entertainment & The Omni Hotel Controversy
This week on The Get Down, John Stanton breaks down the week ahead in New Orleans, including the City Council's final vote on the controversial Omni Hotel redevelopment plan. googletag.cmd.push(function() { googletag.display('ad-1492300'); }); Jake Clapp shares some upcoming entertainment picks, including Ilana Glazer's tour stop at the Joy Theater, and we take a look at summer bucket list ideas in The Pearl for making the most of the season in New Orleans.Be sure to grab a copy of our latest issue of Gambit and stay tuned for the latest on all things New Orleans at bestofneworleans.com. .donate-gambit-article-module-container { text-align: center; padding: 10px; /* background-color: #24da6d; */ background-color: rgb(153, 0, 0); margin-bottom: 20px; } .donate-gambit-article-module-title { font-weight: bold; color: #fff; } .donate-gambit-article-module-copy { color: #fff !important; font-size: 16px; } .donate-gambit-article-module-button { background-color: black; width: 50%; border-color: black; font-size: 16px; } .donate-gambit-article-module-button:hover { background-color: black; } @media only screen and (max-width: 600px) { .donate-gambit-article-module-button { font-size: 14px; width: 100%; } .donate-gambit-article-module-copy { font-size: 14px; } } BECOME A GAMBIT MEMBER AND JOIN OUR KREWE TODAY For more than 40 years, Gambit has covered New Orleans, for New Orleans. We’ve stood up to city hall with you, cheered the Saints with you, danced in the streets with you and cried over our collective loss with you. And we’re plannin’ on being here for 40 more. To do that, we need your help. Become a Gambit member today and help us continue our mission SUPPORT GAMBIT
Zacks Initiates Coverage of Golf Entertainment With Underperform Recommendation
Discover why Zacks rates Golf Entertainment as "Underperform", being the first on Wall Street to initiate coverage on the stock. Explore GLFE's struggles with widening losses, weak entertainment-golf demand and balance-sheet pressure.
Monthly BAT Days Initiative Connects Residents to Free Health, Recovery and Support Services
On the second Wednesday of each month, these organizations come together at the Centers for Addiction and Mental Health Programs (CAMP) on Orange Blossom Trail to provide HIV and Hepatitis-C testing, connections to affordable or free primary care providers, mental health resources and case management services.
Earth’s mantle may be hiding an ocean’s worth of water 410 miles down - Futura-Sciences
An estimated 4.4 billion years ago, a series of planetary collisions delivered the vast majority of Earth’s water budget to a world whose surface was still a bubbling, glowing ocean of molten rock. As this global magma ocean slowly cooled and crystallized over millions of years into the planet’s first...
Future astronauts could walk across rocks from deep inside the Moon
A colossal ancient collision may have left some of the Moon’s deepest secrets surprisingly close to future Artemis landing sites. By recreating the impact that formed the giant South Pole-Aitken basin—the Moon’s largest and oldest crater—scientists found that a low-angle strike from a large, iron-cored object blasted material from deep inside the Moon, including mantle rocks.
Gannon-Doak role 'main topic' for Scotland
Scott Allan believes Ben Gannon-Doak's role in Scotland's final World Cup Group C fixture with Brazil is "the main topic" in how the Scots prepare. The winger started the win against Haiti, playing a role in the winning goal, and came off the bench in the loss to Morocco. "I feel like when we land on the ball, we never really know what the next pass is," former Celtic and Hibernian midfielder Allan told the BBC's Scottish Football Podcast.
What is there to teach a Kennedy about politics? As Jack Schlossberg has found out, a lot
If multiple polls and the wariness of friends who have been helping him are proven right, Jack Schlossberg is facing not just potential rejection in Tuesday’s primary but the prospect of letting down the Kennedy name and all the people who still get excited about it.
North Carolina forces winner-take-all CWS final
The Tar Heels bounced back from a 9-3 loss in Game 1 to force a winner-take-all game Monday night.
Giants downplay Rafael Devers incident late in third consecutive loss
MIAMI — Once again, Rafael Devers is stirring up drama. This time, the Giants first baseman, who refused to play the position with the Red Sox, again tried to stand...
UK Parliament to debate whether to open inquiry into Israel lobby's 'influence' over UK politics
UK parliament is set to debate a petition calling for an inquiry into alleged Israeli influence in British politics after it passed the 100,000-signature threshold.
Twins at Diamondbacks live updates. More moves to bolster staff
The Diamondbacks will look to bounce back from an ugly loss against the Minnesota Twins in the rubber match of a three-game series.
Clalit Health Services to join European AI research project predicting, managing pandemics
Clalit Health Services will join an international consortium of health authorities to create an AI research platform to predict and manage pandemics in advance.
CJ McCollum agrees to return to Hawks on 1-year, $21 million deal
McCollum was responsible for two of the New York Knicks' losses in the 2026 NBA playoffs during a first-round series with the Atlanta Hawks.
Fantasy Baseball 2026: Winners and Losers From Week 12
The Pittsburgh Pirates lost a game in Colorado because of a cleat. The cleat of pinch-runner Billy Cook grazed third baseman Kyle Karros’s glove on a slow ground ball that would have otherwise tied the game. The call gave Paul Skenes a loss instead of a no-decision and surely fantasy baseball results were harmed by the call, which was the actual correct call.
Is hearing loss an Alzheimer’s warning sign? Research shows new risk factors
The number of people living with Alzheimer’s disease is expected to double by 2060. New research is shedding light on warning signs and risk factors that could signal cognitive decline ahead.
Raising the minimum wage has been a big political winner. Now it's running into resistance
Raising the minimum wage has been a progressive policy winner at the ballot box, but recent losses suggest an economic mood slowing its political momentum.
The core life skill we all need to be ready for
Most of us spend our lives trying to avoid experiencing grief to avoid the pain of loss. But avoiding grief doesn’t make our loss hurt less, Megan Shen writes.
Some More Coors Field Frustration for Pirates
A bizarre interference call at third base stifled a bases-loaded rally in Denver, handed the Pittsburgh Pirates another one-run loss, and pushed the struggling club below the .500 mark.
How my dad’s love of the White Sox taught me to look at life and sports differently
Sometimes baseball, and sports in general, is about much more than wins and losses.
2026 MCWS finals: Will Oklahoma's win or UNC's loss carry more of an emotional impact in Game 2?
Instead of dwelling on a win or loss, both UNC and Oklahoma are looking forward to Game 2.
Carlsen, WR Chess Back In Business As World Team Blitz Championship Begins
Magnus Carlsen bounced back from 4 losses in a row to win his first 8 blitz games and wasn't even the highest scorer as WR Chess cruised to victory in Pool A and then eased into the Quarterfinals.
Jack Schlossberg Didn’t Expect a Congressional Campaign Like This
The Kennedy scion’s good looks and zany charm have earned him an online following. But can he win the votes?
Colom prioritizing lower costs, good jobs, affordable health care in state
In 2025, about 27 million people in the United States were medically uninsured, a number that is expected to increase by 10 million in the next decade due to tightened Medicaid eligibility, changes to enrollment processes and a loss of enhanced Affordable Care Act plan subsidies.
Iranian Guards' business empire to win big if US sanctions lifted
Four senior Iranian sources described how the Islamic Revolutionary Guard Corps was uniquely positioned to capture a large share of any financial rewards that would accrue from sanctions relief.
Should everyone be on GLP-1s? What science actually tells us (and doesn't) about the broader health benefits
The laundry list of possible health benefits from GLP-1 drugs seems to get longer by the day, from cancer prevention to combating addiction. But while there’s no question these medications show immense promise beyond their use for diabetes and weight loss, science is still catching up.
🎥 World Cup highlights: What drama, Paraguay knock Turkey out
You couldn’t make this up! Having gone into the World Cup as something of a dark horse, Turkey already has to bow out after just two group-stage matches. The 0–1 loss to Paraguay sealed their earl...
Popular weight-loss drugs linked to unexpected male fertility benefit
GLP-1 drugs like semaglutide and liraglutide do not appear to suppress male hormones and may boost fertility in obese men, new research suggests.
After recent losing endorsements, Donald Trump hedges his bet in South Carolina governor’s race
After recent losses by other candidates he backed, President Donald Trump hedged a major bet Friday by endorsing both of the Republican candidates for South Carolina governor.
Health Ministry investigates suspected Ebola case after traveler develops symptoms
Israel’s Health Ministry is investigating a suspected Ebola case after a traveler returning from the Democratic Republic of Congo developed fever and headache.
New York sports bettors beat the house -
For the first time since New York's online sports wagering went online in 2022, the operators posted a weekly loss for the period ending on June 14th
Saints swept by Omaha in doubleheader
St. Paul was eliminated from first-half playoff contention Thursday evening after being swept in both games of a doubleheader against Omaha at CHS Field. With the losses, the Saints fell to 40-31 with three games remaining in the first half of the International League season. Game 1 Saint Paul knotted at 2-all through three innings before the visiting Storm Chasers put up four runs in the ...
SNP concedes Aberdeen South with Scottish Conservatives set to win
Byelection loss suggests voters rebelled against SNP over Peter Murrell’s theft of £400,000 in party funds
Taking an omega-3 supplement may not boost memory or cognition
Taking an omega-3 fatty acid supplement did not improve memory, cognitive function or brain cell loss for many people, a surprising new study finds.
UVM Health is downsizing. Here’s what those cuts mean for services.
Employee unions are still digesting exactly which positions were eliminated at the state’s largest hospital group, but say the losses are certain to influence patient-facing operations.
I Walked Into a Jack Schlossberg Campaign Event a Skeptic. That’s Not Quite How I Left.
He’s not the least qualified, or the most evil.
Some Asheville businesses that suffered Helene losses ineligible for $14M grant program
Small business owners seeking a share of the more than $14 million Asheville Recovers Together grant are being urged to review eligibility requirements.
Amid Concern Over Xbox Studio 'Bloodbath,' New Report Says Developers Are Being 'Punished Today for Following Orders'
A new report suggests Xbox layoffs will likely result in a "bloodbath" of job losses and studio closures, leaving developers "punished" simply for following Microsoft's orders.
Michelle Beadle Among Biggest Losers Of 2026 NBA Finals
Michelle Beadle has sounded like a pretty big sore loser following the conclusion of the 2026 NBA Finals. Beadle, a lifelong Spurs fan, was understandably disappointed by the result of the 2026 NBA Finals. The Spurs fell to the Knicks, 4-1, blowing big leads in nearly every loss. The future remains ...
Loss of another Seattle-area billionaire? Valve’s Gabe Newell is reported buyer of Florida estate
The Wall Street Journal reported this week that the video game developer is the buyer of a waterfront estate north of Miami.
Before Making a Deal, Trump Demanded Iran’s Surrender. He Got a Surprise.
While the Iranians suffered substantial losses in the war, they emerged from a confrontation with the world’s most powerful military having proved they can use economic chaos as a weapon.
MISMO Updates Business Glossary To Support AI, eMortgages
MISMO has released an updated version of its Business Glossary, expanding standardized definitions across key areas of mortgage lending as the industry continue
Tampa Sports Authority rejects local attorney's claims of conflict of interest
The agency's counsel said the accused members would not see "private gain or loss” if a Rays' stadium was near their properties. Tampa resident Jared Willis, who made the allegations, vowed to press on.
Ozempic users may be making a major weight-loss mistake, new study suggests
New research finds GLP-1 users significantly reduced physical activity, with daily steps and exercise declining after starting a weight loss medication.
Bristol woman helps others regain confidence with new wig business
For Karen Jenkins, hair loss has never been just a personal challenge. It became the reason she opened a business in Bristol aimed at helping others feel confid
‘What am I going to do?’: Some Brown Health patients face loss of UnitedHealthcare coverage
The announcement follows a similar breakdown in contract negotiations over Brown University Health hospitals last year, which led to those hospitals going out of network with certain UnitedHealthca…
Central Florida counselor discusses connection between mental health and GLP-1 weight-loss drugs
Licensed mental health counselor Shantala Boss explores the connection between GLP-1 medications, disordered eating, and body image concerns.
How supplement use changed over decades
Medicare-funded weight loss, Utah's lower drunk driving limit, and more health news from Morning Rounds
GLP-1 and weight-loss drugs: How fast-track health solutions are reshaping FMCG
GLP-1 weight-loss drugs are reshaping FMCG as health, body control, and self-optimization trends redefine consumer behaviour across Europe.
Why healthcare stocks are primed to outperform the market: 2 firms
UBS listed three reasons they like the sector, starting with GLP-1 weight-loss drugs.
Pirates' Jared Jones: Allows two homers in first loss
Pirates' Jared Jones: Allows two homers in first loss
Spurs' Dylan Harper keeping 'positive attitude' after NBA Finals loss
Dylan Harper has separated himself as one of the best young guards in the league following his NBA Finals performance.
Nothing new to report
Truly. Nothing new. Same ol’, same ol’ in this one. A 6-1 loss that felt pre-determined, or determined immediately after Pete Crow-Armstrong homered on the first pitch of the game thrown by Trevor McDonald. PCA continued to be a menace all evening: he collected two more hits, came up a triple shy of the cycle, […]
Victor Wembanyama Accused Of 'Classless' Reaction To NBA Finals Loss
Victor Wembanyama and the San Antonio Spurs fell in five on Saturday night. San Antonio blew a double-digit lead to New York, as the Knicks topped the Spurs, 4-1, in the 2026 NBA Finals. Jalen Brunson, Josh Hart, OG Anunoboy, Karl-Anthony Towns and the rest of the Knicks are NBA champions. ...
What's next for the Spurs? Why the path to building a champion around Wemby could include trading De'Aaron Fox
Following an NBA Finals loss to the Knicks, the Spurs could look to emulate the Thunder's title-winning blueprint